Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 2:47 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1513–1536 of 3,872 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: FAST Clear all

Conditions: Surgical Incision, Nose Deformity
Interventions: Closure with Permanent Suture, Closure with Resorbable Suture; Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 99 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 2
States / cities: Charleston, South Carolina

Conditions: Healthy Subjects
Interventions: levoketoconazole; Drug
Lead sponsor: Cortendo AB; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Lung Cancer, Technology, Oncology
Interventions: Idylla EGFR Mutation Test; Diagnostic Test
Lead sponsor: Anthony Magliocco; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Prediabetes, Prehypertension
Interventions: Vitamin D supplementation; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 7
States / cities: Baton Rouge, Louisiana • Covington, Louisiana • Durham, North Carolina + 1 more

Conditions: Renal Cell Carcinoma (RCC)
Interventions: Intermittent Fasting, Continuous Energy Restriction (CER); Other
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Hepatic Impairment
Interventions: Lemborexant; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 2
States / cities: Miami, Florida • Orlando, Florida

Conditions: Delivery of Health Care, Genetic Testing, Humans, Pregnancy, Noninvasive Prenatal Testing, Informed Consent, Internet-Based Intervention, Self Efficacy, Pregnant People, Decision Making, Health Education, Patient Education as Topic/Method
Interventions: Mobile-based Educational Intervention; Behavioral
Lead sponsor: Case Western Reserve University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 3
States / cities: San Francisco, California • Jacksonville, Florida • Chapel Hill, North Carolina

Conditions: Aging
Interventions: Time Restricted Feeding; Behavioral
Lead sponsor: University of Colorado, Boulder; Other
Eligibility: 55 Years to 79 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Depressive Episode, Posttraumatic Stress Disorder, Traumatic Brain Injury
Interventions: Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation - Sham Comparator; Device
Lead sponsor: INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium; Other
Eligibility: 18 Years to 70 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 2
States / cities: Bethesda, Maryland • Charleston, South Carolina

Conditions: Body Image, Self Esteem, Weight Loss, Health Behavior, Health-Related Behavior, Health Knowledge, Attitudes, Practice
Interventions: FASTer Way Intervention, Control Group Intervention; Other
Lead sponsor: Applied Science & Performance Institute; Industry
Eligibility: 30 Years to 55 Years · Female only
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Post Traumatic Stress Disorder
Interventions: clonazepam and paroxetine; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: Not listed
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2004
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Irritable Bowel Syndrome With Constipation
Interventions: Linaclotide Dose A, Linaclotide Dose B, Linaclotide Dose C, Linaclotide Approved Adult Dose, Matching Placebo; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 7 Years to 17 Years
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 46
States / cities: Hot Springs, Arkansas • Little Rock, Arkansas • Anaheim, California + 39 more

Conditions: Colorectal Cancer, Early Onset Colorectal Cancer, Diet Habit, Risk Reduction
Interventions: Semi Quantitative Food Frequency Questionnaire (SQFFQ); Behavioral
Lead sponsor: San Raffaele University; Other
Eligibility: 18 Years to 49 Years
Enrollment: 2,300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2035
U.S. locations: 2
States / cities: Denver, Colorado • Chicago, Illinois

Conditions: Pulmonary Disease, Chronic Obstructive, Emphysema
Interventions: Silicone Stent Airway Implant; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Atrial Fibrillation, Atrial Flutter
Interventions: Tedisamil sesquifumarate; Drug
Lead sponsor: Solvay Pharmaceuticals; Industry
Eligibility: 18 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 4
States / cities: Los Angeles, California • Santa Ana, California • Honolulu, Hawaii + 1 more

Conditions: Dementia, Postoperative Delirium (POD), Postoperative Neurocognitive Disorder, Major Adverse Cardiac and Cerebrovascular Events, Perioperative Complications, Postoperative Cognitive Decline
Interventions: Personalized CPC Prehabilitation, Cognitive Training, Meditation, Daily Exercise, Enhanced Social Support, Proactive Bundle Interventions, Pre-operative Standard of Care, Intra-operative Standard of Care; Other · Behavioral · Procedure
Lead sponsor: University of Pittsburgh; Other
Eligibility: 65 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 5
States / cities: Pittsburgh, Pennsylvania

Conditions: Multiple Sclerosis
Interventions: Not listed
Lead sponsor: University of Virginia; Other
Eligibility: 10 Years to 20 Years
Enrollment: 116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • Charlottesville, Virginia

Conditions: Healthy
Interventions: crizotinib, ketoconazole; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: South Miami, Florida

Conditions: Vaccine Uptake
Interventions: Communication Campaign; Behavioral
Lead sponsor: Syracuse University; Other
Eligibility: Not listed
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Transtibial Amputation, Peripheral Artery Disease, Diabetes Mellitus
Interventions: Error-augmentation gait training, Error-correction gait training, Supervised walking; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 40 Years to 89 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 2
States / cities: Aurora, Colorado • Richmond, Virginia

Conditions: Healthy
Interventions: Lamotrigine Tablets 25 mg, Lamictal® Tablets 25 mg; Drug
Lead sponsor: Mylan Pharmaceuticals Inc; Industry
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Rapid HIV Screening
Interventions: A: Nontargeted rapid HIV screening, B: Enhanced targeted rapid HIV screening, C: Traditional targeted rapid HIV screening; Other
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 16 Years and older
Enrollment: 76,235 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 4
States / cities: Oakland, California • Denver, Colorado • Baltimore, Maryland + 1 more

Conditions: Drug Interaction
Interventions: BIIB074, Valproic Acid; Drug
Lead sponsor: Biogen; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Diabetes, Obesity
Interventions: Detemir; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 31 Years to 60 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2028
U.S. locations: 1
States / cities: Nashville, Tennessee

Search by objective public record fields.

Rhinoplasty Scar Comparison

Levoketoconazole Food Effect Study in Healthy Subjects

Idylla EGFR Lung Trial

Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study

Comparing Two Weight Loss Programs for the Prevention of Kidney Cancer Progression Among Patients With Small Renal Masses on Active Surveillance

Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared to Healthy Subjects

Supporting Just-In-Time Consent for Prenatal Screening: The INFORM Study

The Effect of Time-restricted Feeding on Physiological Function in Middle-aged and Older Adults

Transcranial Magnetic Stimulation (TMS) for Suicidal Ideation

The Effectiveness on an Application-Based Lifestyle Change Program on Health in Women

Clonazepam and Paroxetine for Rapid Treatment of Post-Traumatic Stress Disorder

A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation

Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer

Evaluating the Clinical Effectiveness of 3D Printing for a Patient-specific Silicone Stent Airway Implant

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects

Prediction and Prevention of Postoperative Mortality and Morbidity

Obesity and Pediatric Multiple Sclerosis

Estimation Of Effect Of Ketoconazole On Pharmacokinetics Of Crizotinib In Healthy Volunteers

Boosting COVID-19 Vaccination Uptake Using Wastewater Surveillance

Optimizing Gait Rehabilitation for Veterans With Non-traumatic Lower Limb Amputation

Fasting Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg

The HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial

Study to Evaluate the Effect of UGT Inhibition by Valproic Acid on the Pharmacokinetics of BIIB074

Insulin Detemir in Obesity Management